Uncategorized
Imprimis reports nearly $1.7 million in total revenues in 2014
Imprimis Pharmaceuticals reported total revenues of $1.66 million in 2014 compared with $10,000 in 2013, according to a press release.In the fourth quarter 2014, revenue was $550,105 compared with $2,500 in the same quarter in 2013. An estimated $299,000 was attributed to the sales of dropless therapy formulations, an estimated 101% increase in revenues for sales compared with the third quarter 2014.